Apath's Incubator/Accelerator Round

Apath raised a round of funding on , . Investors include Nidus Center for Scientific Enterprise.

Apath is a pharmaceutical discovery and development company with a focus on the hepatitis C virus ("HCV") and other human viral pathogens. Apath was founded by Charles M. Rice, Ph.D., currently Profes…

Articles about Apath's Incubator/Accelerator Round: